Page 5 - Nasdaq Atra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

M28 Capital Management LP purchased a new position in shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 439,300 shares of the biotechnology company’s stock, valued at approximately $1,441,000. Atara Biotherapeutics makes […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) CFO Eric J. Hyllengren sold 7,918 shares of the stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $2.04, for a total transaction of $16,152.72. Following the sale, the chief financial officer now directly owns 226,142 shares in the company, […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) CFO Eric J. Hyllengren sold 7,918 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $2.04, for a total transaction of $16,152.72. Following the sale, the chief financial officer now directly owns 226,142 shares […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) EVP Amar Murugan sold 8,389 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $2.04, for a total transaction of $17,113.56. Following the sale, the executive vice president now owns 270,945 shares of the […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has been given a consensus rating of “Hold” by the nine analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average […]